Skip to main content
PLOS One logoLink to PLOS One
. 2024 Mar 8;19(3):e0299826. doi: 10.1371/journal.pone.0299826

Attending physicians’ annual service volume and use of virtual end-of-life care: A population-based cohort study in Ontario, Canada

Rebecca Rodin 1,2, Thérèse A Stukel 3,4, Hannah Chung 3, Chaim M Bell 2,5,6, Allan S Detsky 2,5,6, Sarina Isenberg 7,8,9, Kieran L Quinn 2,3,4,5,6,*
Editor: Masoud Behzadifar10
PMCID: PMC10923452  PMID: 38457383

Abstract

Importance

Physicians and their practice behaviors influence access to healthcare and may represent potentially modifiable targets for practice-changing interventions. Use of virtual care at the end-of-life significantly increased during the COVID-19 pandemic, but its association with physician practice behaviors, (e.g., annual service volume) is unknown.

Objective

Measure the association of physicians’ annual service volume with their use of virtual end-of-life care (EOLC) and the magnitude of physician-attributable variation in its use, before and during the pandemic.

Design, setting and participants

Population-based cohort study using administrative data of all physicians in Ontario, Canada who cared for adults in the last 90 days of life between 01/25/2018-12/31/2021. Multivariable modified Poisson regression models measured the association between attending physicians’ use of virtual EOLC and their annual service volume. We calculated the variance partition coefficients for each regression and stratified by time period before and during the pandemic.

Exposure

Annual service volume of a person’s attending physician in the preceding year.

Main outcomes and measures

Delivery of ≥1 virtual EOLC visit by a person’s attending physician and the proportion of variation in its use attributable to physicians.

Results

Among the 35,825 unique attending physicians caring for 315,494 adults, use of virtual EOLC was associated with receiving care from a high compared to low service volume attending physician; the magnitude of this association diminished during the pandemic (adjusted RR 1.25 [95% CI 1.14, 1.37] pre-pandemic;1.10 (95% CI 1.08, 1.12) during the pandemic). Physicians accounted for 36% of the variation in virtual EOLC use pre-pandemic and 12% of this variation during the pandemic.

Conclusions and relevance

Physicians’ annual service volume was associated with use of virtual EOLC and physicians accounted for a substantial proportion of the variation in its use. Physicians may be appropriate and potentially modifiable targets for interventions to modulate use of EOLC delivery.

Introduction

Physician practice behavior is an important determinant of health outcomes and patients’ access to clinical care [16]. Such behavior may be influenced by physician characteristics, training, practice guidelines, available resources, and financial incentives [79]. During the COVID-19 pandemic, virtual care rapidly expanded in Ontario via introduction of new physician fee codes on March 14, 2020, which reimbursed physician delivery of video- and telephone-based virtual care, including end-of-life care (EOLC). Virtual care has the potential to expand healthcare access, improve convenience and satisfaction with care, and reduce costs through improved clinical efficiency (e.g., reduced visit length, fewer no-shows, increased on-time appointments) [1016]. Virtual visits may be uniquely beneficial for patients near the end of life, for whom mobility outside the home and access to in-person home visiting physicians may be limited [17]. However, the optimal balance of virtual and in-person care remains to be determined.

Health systems may seek interventions to modulate use of virtual EOLC to better achieve such balance. Doing so requires measures that are easily applied and correlated with the use of virtual EOLC. While some patient-level factors, such as age [18], socioeconomic status [19], and frailty [20], may contribute to virtual EOLC use, access to this care remains largely dependent on physician providers. Physicians’ use of virtual EOLC is potentially modifiable; their practice behaviors or other characteristics (e.g., age, sex, years in training, specialty) may be effective screening measures that predict which physicians are more or less likely to use virtual EOLC and therefore the most appropriate targets for intervention. At present, little is known about the extent to which such physician-level factors influence the use of this innovative EOLC delivery model.

Prior research demonstrated that physician practice behaviors, such as their annual referral rate to palliative care, was associated with their patients’ subsequent use of palliative care and dying at home [2]. The Diffusion of Innovation Theory holds that some people are more apt to adopt a new technology than others (e.g., ‘early adopters’ versus ‘laggards’), in part, because of the former’s greater need for such change [21]. Physicians with high service volume may be more likely to utilize a novel clinical delivery model, such as virtual EOLC, because of an expectation that it would improve clinical efficiency, allowing physicians to see a greater number of their patients each day [1013]. Virtual EOLC has the potential to improve health outcomes, expand the pool of palliative care providers, and increase access to care where and when patients need it [1416]. Conversely, overly broad use may result in unnecessary care delivery, thereby increasing overall healthcare costs [15, 22]. As a potential surrogate measure of virtual EOLC utilization, physicians’ annual service volume (i.e., the number of patient visits per year) may serve as a feasible measure to identify physicians who should be targeted for interventions to modulate their virtual EOLC use. To date, no studies have measured the association of a physician’s annual service volume with their use of virtual EOLC.

The objective of this study was to examine whether attending physicians’ annual service volume is associated with the use of virtual EOLC. We measured the magnitude of that variation, how it changed before and during the pandemic, and quantified the variation in use of virtual EOLC attributable to physicians. We hypothesized that physicians with high annual service volumes would be more likely to delivery virtual EOLC to their patients than those with low annual service volumes.

Methods

Study design and setting

We used health administrative data to conduct a population-based cohort study of physicians in Ontario, Canada who provided care to adults in the last 90 days of life. These datasets were linked using unique encoded identifiers and analyzed at ICES (formerly the Institute for Clinical and Evaluative Sciences). ICES houses a vast and secure array of large, linkable and coded health-related databases including administrative and demographic datasets, population-based surveys, disease registries and electronic medical records, as well as a growing number of other non-health administrative data. The description of linked ICES datasets has been provided in S1 Table.

The Mount Sinai Research Ethics Board granted a waiver of consent for this study. ICES is a prescribed entity under Ontario’s Personal Health Information Protection Act (PHIPA). Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under section 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under section 45 and approved by ICES’ Privacy and Legal Office.

Ontario is the most populous province, with nearly 15 million residents, and provides universal access to hospital care and medically necessary physician services to all residents. These data were linked using encoded identifiers and analyzed at ICES, which have been used in multiple prior studies evaluating EOLC delivery in Ontario [2, 2326].

Study participants

Our study cohort included all attending physicians in Ontario who were most responsible for providing care to adults (≥18 years old) in the last 90 days of life who died from any cause over a 3-year period between January 25, 2018, and December 31, 2021. An attending physician was defined as the physician who provided the greatest number of outpatient visits for that person in the year prior to their index date, or who rostered that person as part of a primary care team. Each person had one unique attending physician.

The observation period was the last 90 days of life, beginning at an index date 90 days before death for each person. To partially disentangle the effects of the pandemic from those associated with physician service volume, we studied the periods before and during the pandemic–specifically, before and after March 14, 2020, when new specialized fee codes were introduced to enable virtual care during the pandemic. Physicians were grouped according to whether the care they provided to people in the last 90 days of life occurred before or after the introduction of specialized virtual fee codes on March 14, 2020.

We excluded people who were hospitalized for the entire observation period and those who resided in a nursing home as of the index date, as these individuals may have had limited or no access to virtual care. We also excluded individuals who had no outpatient visits in the last year of life and had not been rostered by a family physician in the last two years of life, as these individuals may be more likely to have died due to sudden, traumatic, or accidental causes, rather than due to a serious illness requiring physician care near the end of life.

Study measures and outcomes

All variables were obtained using records from the ICES database (S1 Table). We measured physician-level characteristics, including age, sex, graduation from a Canadian versus foreign medical school, specialty, status as a palliative care specialist, years in practice, rural practice setting, number of patients and visits in the preceding year, volume of virtual and non-virtual service fee claims for the assigned patient between index date and death, volume of total physician service fee claims in the year prior to the assigned index date, and number of end-of-life visits provided in the year prior to index date. Status as a palliative care specialist was determined using a validated method with a sensitivity of 76.0% and specificity of 97.8% [27].

We also measured the characteristics of their assigned patients in terms of demographic and clinical variables, including age, sex, neighborhood income quintile, location of residence (rural and home/community service networks known as LHINs), surname-based ethnicity [28], comorbidities and chronic conditions [29], Hospital Frailty Index scores [30], recent healthcare use (receipt of palliative care before the last 90 days of life, number of medications, emergency department visits, hospitalizations, and receipt of homecare services in past year) and year of death. The Hospital Frailty Index score is a comprehensive measure of a person’s comorbidity that reflects global illness severity; this score predicts greater risk of adverse outcomes, including hospitalization and 30-day mortality [30].

The main exposure was the annual service volume of a person’s attending physician in the year prior to their index date. The annual service volume is defined as the number of patient visits provided by a physician each year. This was measured for each physician using the number of outpatient visits the attending physician provided to all patients in the year prior to their assigned patient’s index date. We then categorized physicians into percentiles based on their relative annual service volume (“low” [bottom 25%], “high” [top 25%], and “average” [volumes within 25–75%]). We focused on comparing physicians with high vs. low annual service volume because these groups were expected to have the greatest relative difference in outcomes and efforts to modify physician behaviors, such as audit and feedback, are most effective when targeted to physicians with practice patterns at the extremes [31].

The primary outcome was the use of virtual EOLC, defined as ≥1 virtual care visit by an attending physician to their patient in the last 90 days of life. Prior to the pandemic, the only virtual care reimbursed by the universal healthcare plan in Ontario, Canada was for a maximum of two telephone encounters per week, or for specific video-based encounters that required patients to travel to an authorized center. During the pandemic, new specialized fee codes were introduced that reimbursed all video- and telephone-based encounters occurring anywhere within the province, including from a patient’s home. We also measured the proportion of variation in use of virtual EOLC attributable to physicians. The secondary outcomes were: 1) the number of unique visits of any kind provided by an attending physician to their assigned patient during the last 90 days of life; 2) the number of unique virtual visits provided by an attending physician to their assigned patient during the last 90 days of life; and 3) the proportion of virtual visits to total unique visits provided by the attending physician to their assigned patient from index date to death.

Data analysis

Modified Poisson regression was used to measure the association (relative risk) between the use of end-of-life virtual care by attending physicians for their patients and the annual service volume of those physicians, accounting for clustering of people within the same physician. We stratified these analyses by time period before and during the pandemic in order account for the widespread changes in healthcare utilization that occurred during the pandemic. Covariates included in the analytic models were chosen as potential confounders based on the clinical and research expertise of our team, including those that were imbalanced based on a measured standardized differences (SD) assessed at index date of >0.1 [32]. For example, the inclusion of physician age, sex, and specialty as covariates was based on studies showing that younger, female physicians in primary practice care for a fewer number of patients than physicians who are older, male, and specialized; and so these variables may confound measures of annual service volume [33, 34]. For each regression model, we calculated the variance partition coefficient (VPC), which measures the proportion of the variation in use of virtual EOLC that is attributable to physicians. All analyses were performed using SAS version 9.4 (SAS Institute, Cary, North Carolina).

Results

Characteristics of study participants

We included 35,825 unique attending physicians who were paired with 315,494 adults who died during the study period. Prior to the pandemic, there were 18,335 attending physicians, of whom 7,434 (41%) were low, 8,099 (44%) average, and 2,802 (15%) high volume providers. During the pandemic, there were 17,490 attending physicians, of whom 7,876 (45%) were low, 7,221 (41%) average, and 2,393 (14%) high volume providers (Table 1; S2 Table). Among the 315,494 patients in the study, there were 77,826 (25%) people paired with low annual service volume physicians, 158,068 (50%) people paired with average annual service volume physicians, and 79,600 (25%) people paired with high annual service volume physicians (Fig 1).

Table 1. Baseline physician characteristics according to annual service volume before and during the pandemic.

Baseline Physician Characteristic Before the Pandemic During the Pandemic
Annual Physician Practice Volume* Annual Physician Practice Volume*
Low (N = 7,434) High (N = 2,802) Standardized Difference Low (N = 7,876) High (N = 2,393) Standardized Difference
Age (y), mean (SD) 50.1 (13.3) 51.8 (10.6) 0.14 51.0 (13.0) 52.3 (10.5) 0.11
Female sex, n (%) 3,634 (48.9) 629 (22.4) 0.57 3,746 (47.6) 566 (23.7) 0.52
Rural, n (%) 502 (6.8) 55 (2.0) 0.24 600 (7.6) 33 (1.4) 0.3
Canadian medical graduate, n (%) 4,857 (65.3) 1,396 (49.8) 0.32 4,935 (62.7) 1,127 (47.1) 0.32
Years in practice, median (IQR) 22 (12–35) 27 (18–35) 0.22 23 (12–36) 27 (19–35) 0.21
Practice specialty, n (%)
 Family Medicine 4,008 (53.9) 1,941 (69.3) 0.32 4,458 (56.6) 1,643 (68.7) 0.25
 Non-Cancer Specialist 2,422 (32.6) 670 (23.9) 0.19 2,407 (30.6) 568 (23.7) 0.15
 Medical Oncologist 207 (2.8) 39 (1.4) 0.1 173 (2.2) 53 (2.2) 0
 Surgical Oncologist 745 (10.0) 151 (5.4) 0.17 834 (10.6) 129 (5.4) 0.19
Status as a palliative care specialist, n (%) 331 (4.5) 66 (2.4) 0.12 352 (4.5) 97 (4.1) 0.02
Number of patients per physician
 Median (IQR) 3 (1–7) 11 (6–21) 1.17 3 (1–6) 10 (5–19) 1.2
Number of visits in year prior to index 2,221 (1,499–2,826) 9,678 (8,288–12,244) 3.16 2,187 (1,450–2,784) 9,633 (8,255–12,095) 3.06
 Median (IQR)
Number of end-of-life visits in year prior to index**
 Median (IQR) 0 (0–0) 0 (0–1) 0.08 2 (0–7) 10 (3–22) 0.81

SD indicates standard deviation; IQR, interquartile range; MRP, most responsible physician

*See S2 Table for complete table showing physician demographics according to low, average, and high annual service volume before and during the pandemic

**An end-of-life visit is defined by the presence of any of the following billings: 1) Home-based palliative care, 2) Virtual palliative care, 3) Any virtual visit billed with a home-based palliative care fee code in the last year of life, 4) Any virtual visit within the last 90 days of life

Fig 1. Creation of the study cohort.

Fig 1

Within each period, a greater proportion of high compared to low annual volume physicians were male, trained in family medicine, practiced in urban areas, graduated from an international medical school, and, by definition, conducted more patient visits per year (Table 1; S2 Table). The magnitude of these differences were not different before and during the pandemic. The characteristics of the people cared for by each attending physician in each period is shown in S3 Table.

Changes in virtual EOLC by physician annual service volume

Before the pandemic, 4.3% of people cared for by high volume attending physicians and 4.2% of people cared for by low volume attending physicians received at least 1 virtual EOLC visit. During the pandemic, these proportions rose to 58% and 52%, respectively (Table 2). After adjusting for physician- and patient-level characteristics, use of virtual EOLC was associated with receiving care from a high compared to low volume attending physician, though the magnitude of this association diminished during the pandemic (adjusted RR 1.25 [95% CI 1.14, 1.37] pre-pandemic and 1.10 [95% CI 1.08, 1.12] during the pandemic; Table 2). This was also observed for people with high compared to average volume physicians (adjusted RR 1.20 [95% CI 1.11, 1.30] pre-pandemic and 1.02 [95% CI 1.00, 1.03] during the pandemic; Table 2). Overall, the increase in EOLC during the pandemic included a nearly 20-fold increase in the proportion of EOLC visits that occurred virtually (Table 3). Measurement of the VPC showed that physicians accounted for 36% of the variation in use of virtual EOLC in the pre-pandemic period and 12% of this variation during the pandemic (Fig 2).

Table 2. Association between attending physician service volume and use of virtual EOLC to assigned patients according to time period before and during the pandemic.

Annual Physician Service Volume People Receiving ≥1 virtual EOLC Visit by Attending Physician, n (%) Unadjusted Relative Risk (95% C.I.) Adjusted* Relative Risk (95% C.I.)
Before the Pandemic - -
 High 1,954 (4.3)
 Average 3,596 (4.0)
 Low 1,695 (4.2) - -
During the Pandemic
 High 19,823 (57.7)
 Average 38,144 (56.5) - -
 Low 19,377 (52.0)
High vs. Low
 Before- 1.03 (0.97, 1.10) 1.25 (1.14, 1.37)
 During- 1.11 (1.10, 1.13) 1.10 (1.08, 1.12)
Average vs. Low
 Before- 0.95 (0.90, 1.00) 1.03 (0.96, 1.10)
 During- 1.09 (1.08, 1.10) 1.07 (1.06, 1.09)
High vs. Average
 Before- 1.09 (1.03, 1.15) 1.20 (1.11, 1.30)
 During- 1.02 (1.01, 1.03) 1.02 (1.00, 1.03)

* Model adjusted for the following provider-level characteristics: sex, age, practice location (urban vs. rural), practice type as specialist vs. family physician/general practitioner, status as a palliative care billing physician, and number of years in practice; and patient-level characteristics: age, sex, neighborhood income quintile, surname-based ethnicity, rural residence, local health integration network (LHIN), chronic conditions, hospital frailty risk score, homecare in the 2 years prior to index, number of unique medications, acute healthcare use and use of palliative care in the year prior to index

Table 3. Delivery of virtual and non-virtual care by a person’s attending physician in the last 90 days of life according to annual physician service volume, before and during the pandemic.

Before the Pandemic* During the Pandemic*
Low Annual Physician Volume High Annual Physician Volume Low Annual Physician Volume High Annual Physician Volume
Unique virtual EOLC visits delivered to patients by attending physician, mean (SD) 0.06 (0.3) 0.15 (0.6) 1.14 (1.7) 1.83 (1.7)
Unique EOLC visits (in person or virtual) delivered to patients by attending physician, mean (SD) 1.92 (1.8) 2.22 (1.5) 2.18 (2.2) 3.08 (2.2)
Proportion of virtual visits to total unique EOLC visits, % 3.1 6.8 52.3 59.4

*See S4 Table for complete table showing results according to low, average, and high annual service volume before and during the pandemic

Fig 2. Primary analysis.

Fig 2

Forest plot of the adjusted relative risk of the association between attending physicians’ annual service volume with the use of virtual end-of-life care for the pre-March 14, 2020 (blue squares) and post-March 14, 2020 (red circles) groups. The variance partition coefficient (VPC) estimated the magnitude of physician-attributable variation in the use of virtual end-of-life care.

Changes in any EOLC by physician annual service volume

The delivery of any EOLC visits (in-person or virtual) by an attending physician increased in a similar manner to virtual EOLC according to annual physician service volume (Table 3). The delivery of unique EOLC visits of any kind increased during the pandemic, with high compared to low volume physicians delivering more EOLC visits to their assigned patients (2.2 vs. 1.92 visits pre-pandemic; 3.08 vs. 2.18 visits during the pandemic) (Table 3).

Discussion

This population-based study of 35,825 attending physicians most responsible for the care of 315,494 adults at the end of life measured the association between annual physician service volume and the use of virtual EOLC. We found that attending physicians with a high annual service volume were significantly more likely to use virtual EOLC compared to attending physicians with a low annual service volume. The magnitude of this association was attenuated during the pandemic. Further analysis demonstrated that attending physicians accounted for a significant proportion of the variation in the use of virtual EOLC. Taken together, these findings suggest that physician practice behavior (specifically, their annual service volume) and attending physicians themselves play a significant role in the use of virtual EOLC.

The present findings are consistent with prior work showing the impact of physician practice behaviors on clinical care, such as referral to palliative care [1, 4, 23, 3537]. While patients accounted for most of the variation in receipt of virtual EOLC across both time periods, a substantial proportion remained attributable to physicians. Therefore, physicians may present modifiable targets for interventions to effect practice change in the use of virtual EOLC, which may include targeted audit and feedback, education, financial, and policy initiatives [31, 38].

The findings in this study suggest that annual service volume may be an easy and feasible method for identifying physicians most likely to respond to such targeted efforts to either increase or decrease their use of virtual EOL. At present, little is known about the quality, efficacy, and effectiveness of virtual EOLC, its impact on healthcare outcomes, and the optimal balance of in-person and virtual visits. Most research on virtual care was conducted before the onset of the COVID-19 pandemic, when virtual care was sparingly utilized [16, 3942]. Recently published research in this domain has yielded inconsistent results, with some studies showing that an overreliance on virtual care is associated with increased healthcare utilization, including repeat virtual or in-person visits, hospitalizations, and emergency department visits [22, 4345]. Other studies found no such association or mixed results, in addition to high patient satisfaction with virtual care [4650], and public polling indicates that people want continued access to virtual care, particularly for chronic and non-urgent issues [51]. Ongoing efforts to establish the optimal balance of virtual and in-person EOLC can inform physician-targeted interventions to modulate its use, either by increasing or decreasing utilization of such care.

Strengths of this study include its use of a large, population-based sample that minimizes selection bias and the inclusion of a diverse sample of physicians who provided care near the end of life. The massive shift to virtual care delivery during the pandemic due to restrictions on in-person care allowed for the study of virtual EOLC utilization across an entire health system. Further, the relative stability of our sample characteristics before and during the pandemic minimizes the likelihood that our findings are confounded by changes in the types of physicians and patients utilizing virtual EOLC during the pandemic.

Our study also has limitations. First, we did not measure individual patient preferences and their ability to engage in virtual EOLC. Many patients still prefer virtual care, or desire it as a supplement to in-person care, in multiple circumstances including near end-of-life [17, 52], although others may be less able or willing to access virtual EOLC [5355]. Second, the observational design of our study limits our understanding of the causal mechanisms related to our primary findings, which could be partly related to shifts in healthcare delivery during the pandemic. We explored this potential confounding bias by measuring the magnitude of the effects in the pre-pandemic and pandemic periods. The attenuated magnitude of our findings during the pandemic suggests that changes in healthcare delivery during the pandemic may have also had an important effect on virtual EOLC utilization. Third, we lacked information on the nature and quality of care delivered for each virtual EOLC visit, such as whether it focused primarily on palliative and supportive needs or acute or chronic medical management. Specialized fee codes for palliative-specific virtual care were not introduced in Ontario until January 2021, after data collection for this study was completed. Further research is needed to examine the impact of these palliative-specific virtual billing codes on overall end-of-life-care delivery. Fourth, selection bias may have arisen due to the inclusion of physicians who treat people near the end of life, but not of physicians who only treat people earlier in the course of illness. While these characteristics may affect the likelihood to use virtual care technology, this potential bias was mitigated by including a diverse sample of physicians across the health system. Fifth, the study findings may vary according to physician specialty, which we did not specifically examine, and may affect its generalizability, despite adjustment for physicians’ status as either a primary care physician, palliative or other specialist in our analytic models. Sixth, this study focused exclusively on end-of-life care in Ontario, Canada, so generalizability to other domains of care or to other health systems is not yet known.

Future research is needed to develop and evaluate physician-targeted interventions to effect practice change among physicians to either expand or restrict their utilization of virtual EOLC depending on the desired outcome. Policy-makers and health systems developing such interventions may utilize measures of physicians’ annual service volume to identify the physicians most suitable for these interventions, as such measures are easily applied and correlated with virtual EOLC utilization.

Conclusions

Physician practice behavior, as reflected by attending physicians’ annual service volumes, is associated with the use of virtual EOLC and physicians account for a substantial proportion of the variation in its use. Physicians may therefore be an appropriate and potentially modifiable target for interventions to help modulate and standardize access to this new model of EOLC delivery.

Supporting information

S1 Checklist. STROBE statement- checklist of items that should be included in reports of cohort studies.

(PDF)

pone.0299826.s001.pdf (529.1KB, pdf)
S1 Table. Description of linked ICES datasets.

(DOCX)

pone.0299826.s002.docx (33.3KB, docx)
S2 Table. Baseline physician characteristics according to annual service volume before and during the pandemic.

(DOCX)

pone.0299826.s003.docx (16.4KB, docx)
S3 Table. Baseline characteristics of all community-dwelling adults in the last 90 days of life who died in Ontario according to their attending physician’s annual service volume before and during the pandemic.

(DOCX)

pone.0299826.s004.docx (21.6KB, docx)
S4 Table. Delivery of virtual and non-virtual care by a person’s attending physician in the last 90 days of life according to annual physician service volume, before and during the pandemic.

(DOCX)

pone.0299826.s005.docx (13.6KB, docx)

Acknowledgments

The authors would like to express their gratitude to our patient and caregiver partner who assisted in the development of the research questions and interpretation of the main findings. They politely declined the offer to include them as co-authors in recognition of their valuable contributions. We thank IQVIA Solutions Canada Inc. for use of their Drug Information File.

Data Availability

The dataset from this study is held securely in coded form at ICES. While data sharing agreements prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS. The full dataset creation plan and underlying analytic code are available from the authors upon request, understanding that the computer programs may rely upon coding templates or macros that are unique to ICES and are therefore either inaccessible or may require modification. ICES restricts access to information within ICES by role. Information transferred to ICES is received by an “ICES Data Covenantor,” a role assigned to a limited number of ICES staff authorized to handle direct personal identifiers such as name and personal health number. The ICES Data Covenantor removes the direct personal identifiers and replaces them with a confidential ICES identifier or code to enable data linkage. The extent of access to “coded” information is then subject to access levels and permissions, which are based on need. ICES analytic staff, who create project datasets, require and therefore have access to ICES’ data holdings. Others on the ICES project team are permitted to access and use project datasets only, subject to their assigned level of access. Project members who are not ICES affiliated - called “ICES collaborating researchers” – are permitted to receive information that has been summarized at a group level. ICES administers access to information on a project-by-project basis. Permission to access and use information for an ICES project is subject to a privacy impact assessment and approval by ICES’ Privacy and Legal Office. Individuals who are external to ICES may access certain information for their own research subject to research ethics board approval, and are permitted to access de-identified information only.

Funding Statement

This study received funding from the Canadian Institutes of Health Research (CIHR PNN- 177923), the Mount Sinai Hospital-University Health Network AMO Innovation Fund, and Health Canada, Health Care Policy and Strategies Program. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health and the Ministry of Long-Term Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Quinn K.L., et al., Association between Physician Intensity of Antibiotic Prescribing and the Prescription of Benzodiazepines, Opioids and Proton-Pump Inhibitors to Nursing Home Residents: a Population-Based Observational Study. J Gen Intern Med, 2019. 34(12): p. 2763–2771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Quinn K.L., et al., Association Between Palliative Care and Death at Home in Adults With Heart Failure . J Am Heart Assoc, 2020. 9(5): p. e013844. doi: 10.1161/JAHA.119.013844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Robbins J.A., et al., The influence of physician practice behaviors on patient satisfaction. Fam Med, 1993. 25(1): p. 17–20. [PubMed] [Google Scholar]
  • 4.Bertakis K.D., et al., The impact of physician practice style on medical charges. Journal of family practice, 1999. 48: p. 31–36. [PubMed] [Google Scholar]
  • 5.Xierali I.M., Physician Multisite Practicing: Impact on Access to Care. J Am Board Fam Med, 2018. 31(2): p. 260–269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Udell J.A., et al., Primary Care Clinical Volumes, Cholesterol Testing, and Cardiovascular Outcomes. Can J Cardiol, 2023. 39(3): p. 340–349. [DOI] [PubMed] [Google Scholar]
  • 7.Armour B.S., et al., The Effect of Explicit Financial Incentives on Physician Behavior. Archives of Internal Medicine, 2001. 161(10): p. 1261–1266. [DOI] [PubMed] [Google Scholar]
  • 8.Davis D., et al., Impact of Formal Continuing Medical EducationDo Conferences, Workshops, Rounds, and Other Traditional Continuing Education Activities Change Physician Behavior or Health Care Outcomes? JAMA, 1999. 282(9): p. 867–874. doi: 10.1001/jama.282.9.867 [DOI] [PubMed] [Google Scholar]
  • 9.Berger J.T., The Influence of Physicians’ Demographic Characteristics and Their Patients’ Demographic Characteristics on Physician Practice: Implications for Education and Research. Academic Medicine, 2008. 83(1): p. 100–105. [DOI] [PubMed] [Google Scholar]
  • 10.Green L.V., et al., The Impact of Telehealth on Primary Care Physician Panel Sizes: A Modeling Study. J Am Board Fam Med, 2022. 35(5): p. 1007–1014. doi: 10.3122/jabfm.2022.AP.210435 [DOI] [PubMed] [Google Scholar]
  • 11.Andino J.J., et al., THE IMPACT OF VIDEO VISITS ON MEASURES OF CLINICAL EFFICIENCY AND REIMBURSEMENT. Urol Pract, 2021. 8(1): p. 53–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Pennington Z., et al., Positive impact of the pandemic: the effect of post-COVID-19 virtual visit implementation on departmental efficiency and patient satisfaction in a quaternary care center. Neurosurg Focus, 2022. 52(6): p. E10. doi: 10.3171/2022.3.FOCUS2243 [DOI] [PubMed] [Google Scholar]
  • 13.Tsaousis K.T., et al., The concept of virtual clinics in monitoring patients with age-related macular degeneration. Acta Ophthalmol, 2016. 94(5): p. e353–5. [DOI] [PubMed] [Google Scholar]
  • 14.Slavin-Stewart C., Phillips A., and Horton R., A Feasibility Study of Home-Based Palliative Care Telemedicine in Rural Nova Scotia. J Palliat Med, 2020. 23(4): p. 548–551. doi: 10.1089/jpm.2019.0173 [DOI] [PubMed] [Google Scholar]
  • 15.Steindal S.A., et al., Patients’ Experiences of Telehealth in Palliative Home Care: Scoping Review . J Med Internet Res, 2020. 22(5): p. e16218. doi: 10.2196/16218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zheng Y., Head B.A., and Schapmire T.J., A Systematic Review of Telehealth in Palliative Care: Caregiver Outcomes. Telemed J E Health, 2016. 22(4): p. 288–94. doi: 10.1089/tmj.2015.0090 [DOI] [PubMed] [Google Scholar]
  • 17.Vincent D., et al., Virtual home-based palliative care during COVID-19: A qualitative exploration of the patient, caregiver, and healthcare provider experience. Palliative Medicine, 2022. 36(9): p. 1374–1388. doi: 10.1177/02692163221116251 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Walker D.M., et al., Exploring the Digital Divide: Age and Race Disparities in Use of an Inpatient Portal. Telemed J E Health, 2020. 26(5): p. 603–613. doi: 10.1089/tmj.2019.0065 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Katz A.J., et al., Evaluation of Telemedicine Use Among US Patients With Newly Diagnosed Cancer by Socioeconomic Status . JAMA Oncol, 2022. 8(1): p. 161–163. doi: 10.1001/jamaoncol.2021.5784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Liu L., et al., Factors associated with virtual care access in older adults: a cross-sectional study. Age Ageing, 2021. 50(4): p. 1412–1415. doi: 10.1093/ageing/afab021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.EM R., Diffusion of Innovations. 1962, New York: Free Press of Glencoe. [Google Scholar]
  • 22.Lapointe-Shaw L., et al., Characteristics and Health Care Use of Patients Attending Virtual Walk-in Clinics in Ontario, Canada: Cross-sectional Analysis. J Med Internet Res, 2023. 25: p. e40267. doi: 10.2196/40267 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Quinn K.L., et al., Association Between Attending Physicians’ Rates of Referral to Palliative Care and Location of Death in Hospitalized Adults With Serious Illness: A Population-based Cohort Study. Med Care, 2021. 59(7): p. 604–611. doi: 10.1097/MLR.0000000000001524 [DOI] [PubMed] [Google Scholar]
  • 24.Quinn K.L., et al., Association between palliative care and healthcare outcomes among adults with terminal non-cancer illness: population based matched cohort study. Bmj, 2020. 370: p. m2257. doi: 10.1136/bmj.m2257 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Quinn K.L., et al., Regional collaborative home-based palliative care and health care outcomes among adults with heart failure. Cmaj, 2022. 194(37): p. E1274–e1282. doi: 10.1503/cmaj.220784 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Quinn K.L., et al., Complications Following Elective Major Noncardiac Surgery Among Patients With Prior SARS-CoV-2 Infection. JAMA Netw Open, 2022. 5(12): p. e2247341. doi: 10.1001/jamanetworkopen.2022.47341 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Barbera L., et al., Identification of the physician workforce providing palliative care in Ontario using administrative claims data. CMAJ Open, 2015. 3(3): p. E292–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Shah B.R., et al., Surname lists to identify South Asian and Chinese ethnicity from secondary data in Ontario, Canada: a validation study. BMC Med Res Methodol, 2010. 10: p. 42. doi: 10.1186/1471-2288-10-42 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Muggah E., et al., The impact of multiple chronic diseases on ambulatory care use; a population based study in Ontario, Canada. BMC Health Serv Res, 2012. 12: p. 452. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gilbert T., et al., Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet, 2018. 391(10132): p. 1775–1782. doi: 10.1016/S0140-6736(18)30668-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ivers N., et al., Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev, 2012(6): p. Cd000259. doi: 10.1002/14651858.CD000259.pub3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Austin P.C., Assessing balance in measured baseline covariates when using many-to-one matching on the propensity-score. Pharmacoepidemiol Drug Saf, 2008. 17(12): p. 1218–25. doi: 10.1002/pds.1674 [DOI] [PubMed] [Google Scholar]
  • 33.Rotenstein L.S., et al., Gender Differences in Time Spent on Documentation and the Electronic Health Record in a Large Ambulatory Network. JAMA Network Open, 2022. 5(3): p. e223935-e223935. doi: 10.1001/jamanetworkopen.2022.3935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Widdifield J., et al., Feminization of the Rheumatology Workforce: A Longitudinal Evaluation of Patient Volumes, Practice Sizes, and Physician Remuneration. The Journal of Rheumatology, 2021. 48(7): p. 1090–1097. doi: 10.3899/jrheum.201166 [DOI] [PubMed] [Google Scholar]
  • 35.Joynt K.E., Orav E.J., and Jha A.K., Physician volume, specialty, and outcomes of care for patients with heart failure. Circ Heart Fail, 2013. 6(5): p. 890–7. doi: 10.1161/CIRCHEARTFAILURE.112.000064 [DOI] [PubMed] [Google Scholar]
  • 36.Is Volume Related to Outcome in Health Care? A Systematic Review and Methodologic Critique of the Literature. Annals of Internal Medicine, 2002. 137(6): p. 511–520. doi: 10.7326/0003-4819-137-6-200209170-00012 [DOI] [PubMed] [Google Scholar]
  • 37.Bertakis K.D., et al., Physician practice styles and patient outcomes: differences between family practice and general internal medicine. Med Care, 1998. 36(6): p. 879–91. doi: 10.1097/00005650-199806000-00011 [DOI] [PubMed] [Google Scholar]
  • 38.Le Grand Rogers R., et al., Improving emergency physician performance using audit and feedback: a systematic review. Am J Emerg Med, 2015. 33(10): p. 1505–14. doi: 10.1016/j.ajem.2015.07.039 [DOI] [PubMed] [Google Scholar]
  • 39.Webb M., et al., Best Practices for Using Telehealth in Hospice and Palliative Care. J Hosp Palliat Nurs, 2021. 23(3): p. 277–285. doi: 10.1097/NJH.0000000000000753 [DOI] [PubMed] [Google Scholar]
  • 40.Shigekawa E., et al., The Current State Of Telehealth Evidence: A Rapid Review. Health Aff (Millwood), 2018. 37(12): p. 1975–1982. doi: 10.1377/hlthaff.2018.05132 [DOI] [PubMed] [Google Scholar]
  • 41.Bonsignore L., et al., Evaluating the Feasibility and Acceptability of a Telehealth Program in a Rural Palliative Care Population: TapCloud for Palliative Care . J Pain Symptom Manage, 2018. 56(1): p. 7–14. doi: 10.1016/j.jpainsymman.2018.03.013 [DOI] [PubMed] [Google Scholar]
  • 42.Oliver D.P., et al., A systematic review of the evidence base for telehospice. Telemed J E Health, 2012. 18(1): p. 38–47. doi: 10.1089/tmj.2011.0061 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Wang B., et al., Association Between Telemedicine Use in Nonmetropolitan Counties and Quality of Care Received by Medicare Beneficiaries With Serious Mental Illness. JAMA Network Open, 2022. 5(6): p. e2218730-e2218730. doi: 10.1001/jamanetworkopen.2022.18730 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Deslich S., C.A., Expanding Technology in the ICU: The Case for the Utilization of Telemedicine. Telemedicine and e-Health, 2014. 20(5): p. 485–492. doi: 10.1089/tmj.2013.0102 [DOI] [PubMed] [Google Scholar]
  • 45.Liu X., et al., Comparison of Telemedicine Versus In-Person Visits on Impact of Downstream Utilization of Care. Telemed J E Health, 2021. 27(10): p. 1099–1104. doi: 10.1089/tmj.2020.0286 [DOI] [PubMed] [Google Scholar]
  • 46.Kiran T., et al., Are primary care virtual visits associated with higher emergency department use? A cross-sectional analysis from Ontario, Canada. medRxiv, 2022: p. 2022.09.08.22278709. [Google Scholar]
  • 47.Zachrison K.S., Yan Z., and Schwamm L.H., Changes in Virtual and In-Person Health Care Utilization in a Large Health System During the COVID-19 Pandemic . JAMA Network Open, 2021. 4(10): p. e2129973-e2129973. doi: 10.1001/jamanetworkopen.2021.29973 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Orrange S., et al., Patient Satisfaction and Trust in Telemedicine During the COVID-19 Pandemic: Retrospective Observational Study. JMIR Hum Factors, 2021. 8(2): p. e28589. doi: 10.2196/28589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Ramaswamy A., et al., Patient Satisfaction With Telemedicine During the COVID-19 Pandemic: Retrospective Cohort Study . J Med Internet Res, 2020. 22(9): p. e20786. doi: 10.2196/20786 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Cross R.K., et al., A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD). Am J Gastroenterol, 2019. 114(3): p. 472–482. doi: 10.1038/s41395-018-0272-8 [DOI] [PubMed] [Google Scholar]
  • 51.J, L. Most consumers want to keep telehealth after the COVID-19 pandemic. 2021 [cited 2023 February 22]; Available from: https://www.healthcarefinancenews.com/news/most-consumers-want-keep-telehealth-after-covid-19-pandemic.
  • 52.Welch B.M., et al., Patient preferences for direct-to-consumer telemedicine services: a nationwide survey. BMC Health Serv Res, 2017. 17(1): p. 784. doi: 10.1186/s12913-017-2744-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Webber E.C., McMillen B.D., and Willis D.R., Health Care Disparities and Access to Video Visits Before and After the COVID-19 Pandemic: Findings from a Patient Survey in Primary Care. Telemed J E Health, 2022. 28(5): p. 712–719. doi: 10.1089/tmj.2021.0126 [DOI] [PubMed] [Google Scholar]
  • 54.Govier D.J., et al., Differences in access to virtual and in-person primary care by race/ethnicity and community social vulnerability among adults diagnosed with COVID-19 in a large, multi-state health system. BMC Health Serv Res, 2022. 22(1): p. 511. doi: 10.1186/s12913-022-07858-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Eruchalu C.N., et al., The Expanding Digital Divide: Digital Health Access Inequities during the COVID-19 Pandemic in New York City . Journal of Urban Health, 2021. 98(2): p. 183–186. doi: 10.1007/s11524-020-00508-9 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Masoud Behzadifar

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

19 Sep 2023

PONE-D-23-24605Attending Physicians’ Annual Service Volume and Use of Virtual End-of-Life Care: A Population-Based Cohort StudyPLOS ONE

Dear Dr. Quinn,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Nov 03 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Masoud Behzadifar

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. You indicated that ethical approval was not necessary for your study. We understand that the framework for ethical oversight requirements for studies of this type may differ depending on the setting and we would appreciate some further clarification regarding your research. Could you please provide further details on why your study is exempt from the need for approval and confirmation from your institutional review board or research ethics committee (e.g., in the form of a letter or email correspondence) that ethics review was not necessary for this study? Please include a copy of the correspondence as an ""Other"" file.

3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”).

For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research.

4. Please note that funding information should not appear in any section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript.

5. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

6. Thank you for stating the following financial disclosure: 

   "NO"

Please state what role the funders took in the study.  If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 

If this statement is not correct you must amend it as needed. 

Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

8. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

9. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: 1- the introduction effectively sets the context for the study, however, it would be helpful to include more background information such as benefits of telemedicine and its economic impact on reducing costs in providing services.

2-in method section it would be beneficial to explain how attending physicians services volume was defined and measured. Additionally, more information about the confounding variables such as age, sex , specialist types would enhance the quality of the study.

3-it would be worthwhile to include more studies in discussion section.

4-researchers must have an ethical responsibility to report their finding accurately and responsibly.

Reviewer #2: • In title, please specify the location of this study.

• I think you should define and explain the "annual service volume".

• The first paragraph of introduction is too long. Please concise it for better readability.

• Has the protocol of this study been previously registered and indexed somewhere that is publicly available?

• Please use relevant reporting guideline throughout the study (https://www.equator-network.org/wp-content/uploads/2015/10/STROBE_checklist_v4_cohort.pdf ), and upload a copy of completed checklist as supplementary file.

• In discussion, you should discuss the potential biases and effect of them on your findings.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Mar 8;19(3):e0299826. doi: 10.1371/journal.pone.0299826.r002

Author response to Decision Letter 0


12 Jan 2024

Dr. Masoud Behzadifar

Academic Editor

PLOS ONE

PONE-D-23-24605 “Attending Physicians’ Annual Service Volume and Use of Virtual End-of-Life Care: A Population-Based Cohort Study in Ontario, Canada.”

Thank you for providing us the opportunity to resubmit our work to PLOS One. We are pleased that the editors and reviewers found our study to be important, valuable, relevant, and of considerable interest. Their helpful suggestions and comments have helped us to improve the paper. We have addressed their concerns in detail below.

The following is a summary of the extensive changes we made to the manuscript in response to yours and the reviewer’s suggestions:

1) Added more fulsome discussion with additional citations to place work in context of current understanding and knowledge about telemedicine.

2) Provided additional background information and citations on the potential benefits of telemedicine.

3) Added details on covariates and a supplementary table providing detail of datasets used to measure them.

4) Further discussed potential sources of bias.

5) Clarified methodological details on the definition of a physician’s annual service volume and its measurement.

6) Modified the title to include the location of study.

7) Provided detail on research ethics exemption and designated status of ICES as a prescribed entity in Ontario.

8) Updated formatting of the manuscript to align with journal-specific requirements.

1. Journal Requirements

1.1 Please ensure that your manuscript meets PLOS ONE’s style requirements, including those for file naming.

We have updated the manuscript as per PLOS ONE's style requirements.

1.2 Could you please provide further details on why your study is exempt from the need for approval and confirmation from your institutional review board or research ethics committee (e.g., in the form of a letter or email correspondence) that ethics review was not necessary. Please include a copy of the correspondence as an “Other” file.

The administrative datasets used in this study were linked using encoded identifiers at the person-level at ICES (formerly the Institute for Clinical and Evaluative Sciences). ICES is a prescribed entity under Ontario’s Personal Health Information Protection Act (PHIPA). Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under section 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under section 45 and approved by ICES’ Privacy and Legal Office. Details about this exemption have been added to the manuscript (Methods, page 5, lines 188-195).

We have included the copy of the waiver from our institutional review board as an “Other” file with our submission.

1.3. Please provide additional details regarding participant consent [and] ensure that you have specified what type of consent you obtained. …If the need for consent was waived… please include this information.

We have uploaded the waiver letter from our institutional Research Ethics Board, updated the 'Ethics Statement' field of the submission form and added rationale in the methods section for not obtaining participant consent as follows,

“The Mount Sinai Research Ethics Board granted a waiver of consent for this study. ICES is a prescribed entity under Ontario’s Personal Health Information Protection Act (PHIPA). Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under section 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under section 45 and approved by ICES’ Privacy and Legal Office.” (Methods, page 5, lines 188-195)

1.4. Please remove any funding-related text from the manuscript.

We have removed funding-related text from the manuscript.

1.5. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match… Please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

We have updated the Funding Information’ and ‘Financial Disclosure, ensured that they match, and have added grant numbers for the awards.

1.6. Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf.

We have now added the suggested statement to the online financial disclosure form: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.”

1.7. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found… Please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail.

We previously indicated our data availability in our manuscript as follows,

“The dataset from this study is held securely in coded form at ICES. While data sharing agreements prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS. The full dataset creation plan and underlying analytic code are available from the authors upon request, understanding that the computer programs may rely upon coding templates or macros that are unique to ICES and are therefore either inaccessible or may require modification.” (Data Sharing, page 16, lines 539-544)

1.8. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

Please see our response #1.7 on data access.

1.9. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well.

We added the ethics statement in the “Methods” section as follows,

“The Mount Sinai Research Ethics Board granted a waiver of consent for this study. ICES is a prescribed entity under Ontario’s Personal Health Information Protection Act (PHIPA). Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under section 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under section 45 and approved by ICES’ Privacy and Legal Office.” (Methods, page 5, lines 188-195)

2. Reviewer Comments

2.1. In title, please specify the location of the study [R2].

The study title has been revised to include the location of the study in Ontario, Canada (page 1, line 3).

2.2. It would be helpful to include more background information [in the introduction], such as benefits of telemedicine, its economic impact on reducing costs in providing services [R1].

We added additional background information and references on the potential benefits of telemedicine as follows,

“Virtual care has the potential to expand healthcare access, improve convenience and satisfaction with care, and reduce costs through improved clinical efficiency (e.g., reduced visit length, fewer no-shows, increased on-time appointments). [10-16] Virtual visits may be uniquely beneficial for patients near the end of life, for whom mobility outside the home and access to in-person home visiting physicians may be limited.[17] However, the optimal balance of virtual and in-person care remains to be determined.” (Introduction, page 3, lines 112-117).

Citations:

10. Green, L.V., et al., The Impact of Telehealth on Primary Care Physician Panel Sizes: A Modeling Study. J Am Board Fam Med, 2022. 35(5): p. 1007-1014.

11. Andino, J.J., et al., The Impact of Video Visits on Measures of Clinical Efficiency and Reimbursement. Urol Pract, 2021. 8(1): p. 53-57.

12. Pennington, Z., et al., Positive impact of the pandemic: the effect of post-COVID-19 virtual visit implementation on departmental efficiency and patient satisfaction in a quaternary care center. Neurosurg Focus, 2022. 52(6): p. E10.

13. Tsaousis, K.T., et al., The concept of virtual clinics in monitoring patients with age-related macular degeneration. Acta Ophthalmol, 2016. 94(5): p. e353-5.

14. Slavin-Stewart, C., A. Phillips, and R. Horton, A Feasibility Study of Home-Based Palliative Care Telemedicine in Rural Nova Scotia. J Palliat Med, 2020. 23(4): p. 548-551.

15. Steindal, S.A., et al., Patients' Experiences of Telehealth in Palliative Home Care: Scoping Review. J Med Internet Res, 2020. 22(5): p. e16218.

16. Zheng, Y., B.A. Head, and T.J. Schapmire, A Systematic Review of Telehealth in Palliative Care: Caregiver Outcomes. Telemed J E Health, 2016. 22(4): p. 288-94.

17. Vincent, D., et al., Virtual home-based palliative care during COVID-19: A qualitative exploration of the patient, caregiver, and healthcare provider experience. Palliative Medicine, 2022. 36(9): p. 1374-1388.

2.3. The first paragraph is too long [R2].

We revised the first paragraph to be more concise. (Introduction, page 3, lines 110-125).

2.4. In method section it would be beneficial to explain how attending physicians services volume was defined and measured [R1]. Define and explain the “annual service volume” [R2].

We clarified additional details on the definition of a physician’s annual service volume and its measurement as follows,

“. The annual service volume is defined as the number of patient visits provided by a physician each year. This was measured for each physician using the number of outpatient visits the attending physician provided to all patients in the year prior to their assigned patient’s index date. We then categorized physicians into percentiles based on their relative annual service volume (“low” [bottom 25%], “high” [top 25%], and “average” [volumes within 25-75%]).” (Methods, page 7, lines 258-262).

We added the following clarification to the introduction,

“…physicians’ annual service volume (i.e., the number of patient visits per year) may serve as a feasible measure to identify physicians for targeted interventions to modulate virtual EOLC use.” (Introduction, page 4, lines 154-155)

2.5. More information about the confounding variables, such as age, sex, specialist types, would enhance the quality of the study [R1].

We provided additional information about confounding variables as follows,

“the inclusion of physician age, sex, and specialty as covariates was based on studies showing that younger, female physicians in primary practice care for a fewer number of patients than physicians who are older, male, and specialized; and so these variables may confound measures of annual service volume.[33, 34]” (Methods, page 8, lines 305-308)

We also added a supplementary table describing the linked datasets used in this study, including the ICES Physician Database that describes how physician characteristics were measured (S1 Table).

2.6. It would be worthwhile to include more studies in discussion section [R1].

Additional studies have been included in the discussion section (references 1, 4, 35-38, 44, 45, 48). References 1, 4, 35-37 (Discussion, page 13, line 406) are studies on the impact of physician practice behaviors, such as their referral patterns and practice volume, on health outcomes; reference 38 is a systematic review of the use of targeted audit and feedback interventions to improve physician performance (page 13, line 410); and references 44, 45, and 48 are studies on the impact of virtual care on subsequent healthcare utilization (page 14, lines 423-424).

2.5. In discussion, you should discuss the potential biases and effect of them on your findings [R2].

Further discussion of potential biases and their effect on our findings have been added to the discussion as follows,

“Second, the observational design of our study limits our understanding of the causal mechanisms related to our primary findings, which could be partly related to shifts in healthcare delivery during the pandemic. We explored this potential confounding bias by measuring the magnitude of the effects in the pre-pandemic and pandemic periods. The attenuated magnitude of our findings during the pandemic suggests that changes in healthcare delivery during the pandemic may have also had an important effect on virtual EOLC utilization. Third, we lacked information on the nature and quality of care delivered for each virtual EOLC visit, such as whether it focused primarily on palliative and supportive needs or acute or chronic medical management. Specialized fee codes for palliative-specific virtual care were not introduced in Ontario until January 2021, after data collection for this study was completed. Further research is needed to examine the impact of these palliative-specific virtual billing codes on overall end-of-life-care delivery. Fourth, selection bias may have arisen due to the inclusion of physicians who treat people near the end of life, but not of physicians who only treat people earlier in the course of illness. While these characteristics may affect the likelihood to use virtual care technology, this potential bias was mitigated by including a diverse sample of physicians across the health system. Fifth, the study findings may vary according to physician specialty, which we did not specifically examine, and may affect its generalizability, despite adjustment for physicians’ status as either a primary care physician, palliative or other specialist in our analytic models. Sixth, this study focused exclusively on end-of-life care in Ontario, Canada, so generalizability to other domains of care or to other health systems is not yet known.” (page 14-15, lines 439-506).

2.6. Report… funding accurately and responsibly [R1].

All funding-related text has been removed from the manuscript. Funding has been reported accurately and consistently in the ‘Funding Information’ section. See response #1.7 above.

2.7. Has the protocol of this study been previously registered and indexed somewhere that is publicly available? [R2].

The study protocol was not previously registered or indexed in a publicly available location. Upon request, the dataset creation plan can be provided as per ICES policy.

2.8. Please use relevant reporting guideline throughout the study (https://www.equator-network.org/wp-content/uploads/2015/10/STROBE_checklist_v4_cohort.pdf ), and upload a copy of completed checklist as supplementary file [R2].

The manuscript has been revised throughout based on the STROBE reporting guideline. A completed checklist is submitted as a supplementary file.

Thank you in advance for your consideration,

Kieran L. Quinn, MD PhD

E-mail: kieran.quinn@sinaihealth.ca

Assistant Professor, Department of Medicine, University of Toronto, Toronto, ON, Canada

Clinician-Scientist, Sinai Health System and University Health Network, Toronto, ON, Canada

Adjunct Scientist, ICES, Toronto and Ottawa, ON, Canada

Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada

Attachment

Submitted filename: Response to Reviewers_PLOS one.docx

pone.0299826.s006.docx (41.3KB, docx)

Decision Letter 1

Masoud Behzadifar

16 Feb 2024

Attending physicians’ annual service volume and use of virtual end-of-life care: a population-based cohort study in Ontario, Canada

PONE-D-23-24605R1

Dear Dr. Quinn,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Masoud Behzadifar

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

**********

Acceptance letter

Masoud Behzadifar

27 Feb 2024

PONE-D-23-24605R1

PLOS ONE

Dear Dr. Quinn,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Masoud Behzadifar

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE statement- checklist of items that should be included in reports of cohort studies.

    (PDF)

    pone.0299826.s001.pdf (529.1KB, pdf)
    S1 Table. Description of linked ICES datasets.

    (DOCX)

    pone.0299826.s002.docx (33.3KB, docx)
    S2 Table. Baseline physician characteristics according to annual service volume before and during the pandemic.

    (DOCX)

    pone.0299826.s003.docx (16.4KB, docx)
    S3 Table. Baseline characteristics of all community-dwelling adults in the last 90 days of life who died in Ontario according to their attending physician’s annual service volume before and during the pandemic.

    (DOCX)

    pone.0299826.s004.docx (21.6KB, docx)
    S4 Table. Delivery of virtual and non-virtual care by a person’s attending physician in the last 90 days of life according to annual physician service volume, before and during the pandemic.

    (DOCX)

    pone.0299826.s005.docx (13.6KB, docx)
    Attachment

    Submitted filename: Response to Reviewers_PLOS one.docx

    pone.0299826.s006.docx (41.3KB, docx)

    Data Availability Statement

    The dataset from this study is held securely in coded form at ICES. While data sharing agreements prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS. The full dataset creation plan and underlying analytic code are available from the authors upon request, understanding that the computer programs may rely upon coding templates or macros that are unique to ICES and are therefore either inaccessible or may require modification. ICES restricts access to information within ICES by role. Information transferred to ICES is received by an “ICES Data Covenantor,” a role assigned to a limited number of ICES staff authorized to handle direct personal identifiers such as name and personal health number. The ICES Data Covenantor removes the direct personal identifiers and replaces them with a confidential ICES identifier or code to enable data linkage. The extent of access to “coded” information is then subject to access levels and permissions, which are based on need. ICES analytic staff, who create project datasets, require and therefore have access to ICES’ data holdings. Others on the ICES project team are permitted to access and use project datasets only, subject to their assigned level of access. Project members who are not ICES affiliated - called “ICES collaborating researchers” – are permitted to receive information that has been summarized at a group level. ICES administers access to information on a project-by-project basis. Permission to access and use information for an ICES project is subject to a privacy impact assessment and approval by ICES’ Privacy and Legal Office. Individuals who are external to ICES may access certain information for their own research subject to research ethics board approval, and are permitted to access de-identified information only.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES